Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 120.69
MED's Cash to Debt is ranked higher than
81% of the 1126 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.13 vs. MED: 120.69 )
MED' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 120.69

Equity to Asset 0.76
MED's Equity to Asset is ranked higher than
93% of the 1117 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.50 vs. MED: 0.76 )
MED' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.8
Current: 0.76

0.26
0.8
F-Score: 7
Z-Score: 11.59
M-Score: -3.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.41
MED's Operating margin (%) is ranked higher than
84% of the 1081 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.46 vs. MED: 9.41 )
MED' s 10-Year Operating margin (%) Range
Min: -44.4   Max: 14.83
Current: 9.41

-44.4
14.83
Net-margin (%) 6.72
MED's Net-margin (%) is ranked higher than
84% of the 1081 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.54 vs. MED: 6.72 )
MED' s 10-Year Net-margin (%) Range
Min: -68.63   Max: 33.43
Current: 6.72

-68.63
33.43
ROE (%) 24.35
MED's ROE (%) is ranked higher than
94% of the 1063 Companies
in the Global Specialty Retail industry.

( Industry Median: 9.36 vs. MED: 24.35 )
MED' s 10-Year ROE (%) Range
Min: -183.38   Max: 107.69
Current: 24.35

-183.38
107.69
ROA (%) 18.07
MED's ROA (%) is ranked higher than
97% of the 1079 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.38 vs. MED: 18.07 )
MED' s 10-Year ROA (%) Range
Min: -151.14   Max: 41.7
Current: 18.07

-151.14
41.7
ROC (Joel Greenblatt) (%) 83.28
MED's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 1078 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.96 vs. MED: 83.28 )
MED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -203.25   Max: 83.28
Current: 83.28

-203.25
83.28
Revenue Growth (%) 13.50
MED's Revenue Growth (%) is ranked higher than
88% of the 982 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.30 vs. MED: 13.50 )
MED' s 10-Year Revenue Growth (%) Range
Min: -45.9   Max: 63.6
Current: 13.5

-45.9
63.6
EBITDA Growth (%) 8.10
MED's EBITDA Growth (%) is ranked higher than
75% of the 806 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.10 vs. MED: 8.10 )
MED' s 10-Year EBITDA Growth (%) Range
Min: 8.1   Max: 78.8
Current: 8.1

8.1
78.8
EPS Growth (%) 8.60
MED's EPS Growth (%) is ranked higher than
74% of the 775 Companies
in the Global Specialty Retail industry.

( Industry Median: 7.20 vs. MED: 8.60 )
MED' s 10-Year EPS Growth (%) Range
Min: -12.1   Max: 68.9
Current: 8.6

-12.1
68.9
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

MED Guru Trades in Q2 2013

Chuck Royce 155,000 sh (New)
Richard Snow 44,490 sh (+9.31%)
Jim Simons 356,000 sh (-10.26%)
Steven Cohen 19,173 sh (-30.78%)
Paul Tudor Jones 11,300 sh (-57.99%)
» More
Q3 2013

MED Guru Trades in Q3 2013

Richard Snow 57,105 sh (+28.35%)
Chuck Royce 168,000 sh (+8.39%)
Jim Simons 377,700 sh (+6.1%)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
» More
Q4 2013

MED Guru Trades in Q4 2013

Paul Tudor Jones 9,600 sh (New)
Richard Snow 78,325 sh (+37.16%)
Chuck Royce 168,000 sh (unchged)
Jim Simons 340,400 sh (-9.88%)
» More
Q1 2014

MED Guru Trades in Q1 2014

Steven Cohen 10,301 sh (New)
Richard Snow 93,880 sh (+19.86%)
Chuck Royce 168,000 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 260,684 sh (-23.42%)
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Sold Out 0.04%$25.41 - $32.28 $ 28.670%0
Joel Greenblatt 2012-09-30 Reduce -24.11%0.01%$19.97 - $28.75 $ 28.6714%25273
Joel Greenblatt 2012-06-30 Reduce -67.4%0.11%$16.46 - $19.82 $ 28.6756%33302
Joel Greenblatt 2012-03-31 Add 45.49%0.05%$14.78 - $17.73 $ 28.6786%102169
Joel Greenblatt 2011-12-31 Add 31.87%0.03%$13.01 - $17.3 $ 28.6788%70224
Joel Greenblatt 2011-09-30 Add 116.95%0.08%$14.46 - $24.36 $ 28.6757%53253
George Soros 2011-09-30 Sold Out 0.0028%$14.46 - $24.36 $ 28.6757%0
Joel Greenblatt 2011-06-30 New Buy0.08%$15.95 - $26.72 $ 28.6733%24546
George Soros 2011-06-30 New Buy$15.95 - $26.72 $ 28.6733%8500
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 16.30
MED's P/E(ttm) is ranked higher than
78% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 22.10 vs. MED: 16.30 )
MED' s 10-Year P/E(ttm) Range
Min: 8.98   Max: 104.82
Current: 16.3

8.98
104.82
P/B 3.60
MED's P/B is ranked higher than
53% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.90 vs. MED: 3.60 )
MED' s 10-Year P/B Range
Min: 1.32   Max: 12.46
Current: 3.6

1.32
12.46
P/S 1.10
MED's P/S is ranked higher than
58% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.80 vs. MED: 1.10 )
MED' s 10-Year P/S Range
Min: 0.49   Max: 7.92
Current: 1.1

0.49
7.92
PFCF 13.90
MED's PFCF is ranked higher than
86% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 36.66 vs. MED: 13.90 )
MED' s 10-Year PFCF Range
Min: 8.43   Max: 165
Current: 13.9

8.43
165
EV-to-EBIT 8.85
MED's EV-to-EBIT is ranked higher than
85% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 16.27 vs. MED: 8.85 )
MED' s 10-Year EV-to-EBIT Range
Min: 4.8   Max: 67
Current: 8.85

4.8
67
PEG 1.10
MED's PEG is ranked higher than
87% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.75 vs. MED: 1.10 )
MED' s 10-Year PEG Range
Min: 0.2   Max: 1.6
Current: 1.1

0.2
1.6
Shiller P/E 23.80
MED's Shiller P/E is ranked higher than
84% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 9999.00 vs. MED: 23.80 )
MED' s 10-Year Shiller P/E Range
Min: 12.14   Max: 96.69
Current: 23.8

12.14
96.69
Current Ratio 3.69
MED's Current Ratio is ranked higher than
93% of the 1120 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.61 vs. MED: 3.69 )
MED' s 10-Year Current Ratio Range
Min: 0.99   Max: 6.73
Current: 3.69

0.99
6.73
Quick Ratio 3.10
MED's Quick Ratio is ranked higher than
95% of the 1120 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.87 vs. MED: 3.10 )
MED' s 10-Year Quick Ratio Range
Min: 0.46   Max: 4.52
Current: 3.1

0.46
4.52

Valuation & Return

vs
industry
vs
history
Price/Net Cash 8.70
MED's Price/Net Cash is ranked higher than
96% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 9999.00 vs. MED: 8.70 )
MED' s 10-Year Price/Net Cash Range
Min: 8.3   Max: 382.25
Current: 8.7

8.3
382.25
Price/Net Current Asset Value 7.20
MED's Price/Net Current Asset Value is ranked higher than
91% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 9999.00 vs. MED: 7.20 )
MED' s 10-Year Price/Net Current Asset Value Range
Min: 6.76   Max: 400
Current: 7.2

6.76
400
Price/Tangible Book 3.60
MED's Price/Tangible Book is ranked higher than
59% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.81 vs. MED: 3.60 )
MED' s 10-Year Price/Tangible Book Range
Min: 1.11   Max: 22.96
Current: 3.6

1.11
22.96
Price/DCF (Projected) 1.00
MED's Price/DCF (Projected) is ranked higher than
89% of the 1170 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.19 vs. MED: 1.00 )
MED' s 10-Year Price/DCF (Projected) Range
Min: 1.02   Max: 11.38
Current: 1

1.02
11.38
Price/Median PS Value 0.90
MED's Price/Median PS Value is ranked higher than
79% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.08 vs. MED: 0.90 )
MED' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 4.83
Current: 0.9

0.18
4.83
Price/Peter Lynch Fair Value 1.00
MED's Price/Peter Lynch Fair Value is ranked higher than
91% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 9999.00 vs. MED: 1.00 )
MED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 3.48
Current: 1

0.4
3.48
Price/Graham Number 1.60
MED's Price/Graham Number is ranked higher than
71% of the 1171 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.07 vs. MED: 1.60 )
MED' s 10-Year Price/Graham Number Range
Min: 0.17   Max: 5.64
Current: 1.6

0.17
5.64
Earnings Yield (Greenblatt) 11.40
MED's Earnings Yield (Greenblatt) is ranked higher than
81% of the 1029 Companies
in the Global Specialty Retail industry.

( Industry Median: 7.30 vs. MED: 11.40 )
MED' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 20.7
Current: 11.4

1.5
20.7
Forward Rate of Return (Yacktman) 20.00
MED's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 839 Companies
in the Global Specialty Retail industry.

( Industry Median: 8.99 vs. MED: 20.00 )
MED' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.4   Max: 53
Current: 20

-1.4
53

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail
Compare:TSCO, AMZN, EBAY, FIVE, AZO » details
Traded in other countries:MDF.Germany
Medifast, Inc., is a Delaware Corporation, incorporated in 1993. The Company is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. Its product lines include meal replacements and vitamins. The Company's products and services are sold to weight loss program participants mainly via the Internet, telephone, and brick and mortar clinics. It has two reportable operating segments: Medifast, and MWCC and Wholesale. Its reporting segment consists of the following distribution channels: Medifast Direct and Take Shape for Life. The MWCC and Wholesale segment consists of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians. At December 31, 2012, the companies Weight Control Centers were operating in eighty-seven corporate locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia, and thirty-five franchise centers were in operation. The Company produced new and reformulated items including Medifast Cinnamon & Brown Sugar Cereal Crunch, Medifast Mixed Berry Cereal Crunch, Medifast Macaroni & Cheese, Medifast Lean & Green Meal Helpers, Medifast Chili Nacho Cheese Puffs, Medifast Parmesan Cheese Puffs, Medifast Ready to Drink Mocha Shake, and the reformulation of the Medifast Shake. It offers an in-house support program to assist the physicians and their customers/patients. Customers have access to registered dietitians who provide program support and advice via a toll-free telephone help line, by email, and online chats. The Company with the help of Facebook, Twitter, YouTube, blogger endorsements, and more has targeted new customers by stressing its simple, safe, and effective approach to weight loss and management. The formulation, processing, packaging, and labeling of the Company's products are subject to regulation by several federal agencies, but mainly by the Food and Drug Administration.
» More Articles for MED

Headlines

Articles On GuruFocus.com
comment on MED Mar 06 2013 
How Are GuruFocus Model Portfolios Faring Beside the Market in 2012? Dec 28 2012 
5-Star Predictable Companies with Highest ROA Mar 20 2012 
Medifast – 5-Star Predictability Rating Stock That Can Be Bought Cheaper Than Price Joel Greenblat Jan 12 2012 
waiting to break dow Dec 02 2011 
Weekly Top Insider Buys: PM, AIG, GM, DOW, MED May 30 2011 
Re: Value Research Analysis on Sandridge Energy Mar 11 2011 
Medifast Inc. (MED) President and COO Margaret Macdonald Sheetz sells 15,000 Shares Jan 07 2011 
Medifast Inc. (MED) CFO Brendan Connors sells 20,000 Shares Jan 07 2011 
Medifast Inc. (MED) Exec. Chairman of the Board Bradley T Macdonald sells 50,000 Shares Jan 07 2011 

More From Our Partners
Why Amedisys (AMED) Stock Is Up Today Jul 30 2014 - THESTREET

More From Other Websites
NYSE stocks posting largest volume increases Jul 30 2014
Take Shape For Life Launches Habits of Healthy Sleep Set Jul 30 2014
Take Shape For Life Launches Habits of Healthy Sleep Set Jul 30 2014
Medifast Adds New Snacks to Product Line Jul 22 2014
The Daily Record Names Medifast's Michael MacDonald a "Most Admired CEO" Jul 21 2014
The Daily Record Names Medifast's Michael MacDonald a "Most Admired CEO" Jul 21 2014
Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2014 Jul 21 2014
Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2014 Jul 21 2014
Medifast Inc. Launches Digital Campaign with Reality TV Chef Jul 07 2014
Medifast Inc. Launches Digital Campaign with Reality TV Chef Jul 07 2014
Medifast Builds on Clinical Heritage with Addition of Three Members to its Scientific Advisory Board Jun 30 2014
Medifast Conducts National Survey on Summer Eating Habits Jun 26 2014
MEDIFAST INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles... Jun 20 2014
INVESTOR ALERT - The Law Offices of Vincent Wong Investigating Medifast Inc. (MED), Molina... Jun 19 2014
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure Jun 19 2014
Medifast's "Conversations with Yourself" Campaign Wins Gold at Effie Awards Gala Jun 16 2014
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of... Jun 16 2014
MEDIFAST INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation... Jun 10 2014
Medifast, Inc. to Participate in the Jefferies 2014 Global Consumer Conference Jun 05 2014
MEDIFAST INC Files SEC form 8-K, Other Events Jun 03 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide